Atulkumar Thakorlal Shah, MD
Gastroenterology · Arlington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Texas Digestive Disease Consultants, PLLC · 616 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shah’s office at (817) 394-4300 to ask if they take your plan before you enroll.
California Medical Board record
Licence C167727 · Current
Licensed to practise in California · since 2020 · expires 2028-01-31 · M. S. University of Baroda Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas J1039Physician License · since 1992 · expires 2027-02-28ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$43,420
Medicare paid this office $43,420 for 239 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 92 | $11,493 | $98 |
| New patient visit (60+ min) | 36 | $5,986 | $166 |
| New patient visit (45+ min) | 41 | $5,197 | $127 |
| Long return visit (40+ min) | 33 | $4,718 | $135 |
| Biopsy of large bowel using a flexible endoscope | 30 | $4,218 | $141 |
See all 10 services
| Return visit (30+ min) | 92 | $11,493 | $98 |
| New patient visit (60+ min) | 36 | $5,986 | $166 |
| New patient visit (45+ min) | 41 | $5,197 | $127 |
| Long return visit (40+ min) | 33 | $4,718 | $135 |
| Biopsy of large bowel using a flexible endoscope | 30 | $4,218 | $141 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,291 | $235 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,021 | $92 |
| Short return visit (20+ min) | 20 | $1,298 | $62 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 20 | $296 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 35 | $170 | $5 |
Procedures Medicare counted
| Colonoscopy | 15 | More than 44% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 14 | More than 46% of doctors who do this |
Who their Medicare patients are
239 Original Medicare patients in 2024. Average age 72 · Under 65 11% · 85 and older 7% · Women 59% · Also on Medicaid 41% · Health risk score 1.54. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 69% · Diabetes 40% · Chronic kidney disease 28% · Coronary heart disease 24% · Depression 21% · Cancer 20% · Heart failure 15% · Atrial fibrillation 15% · COPD 14% · Dementia 7% · Stroke 5%.
The office billed $315,364, Medicare allowed $56,220 and paid $43,420; for 410 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 239 | 410 | 72 | 1.54 | $315,364 | $43,420 |
| 2023 | 300 | 481 | 72 | 1.52 | $288,600 | $41,535 |
| 2022 | 339 | 542 | 72 | 1.83 | $346,175 | $47,093 |
| 2021 | 302 | 532 | 72 | 1.65 | $372,289 | $50,087 |
| 2020 | 359 | 567 | 72 | 1.49 | $333,244 | $41,305 |
| 2019 | 603 | 1,083 | 72 | 1.43 | $468,557 | $91,663 |
| 2018 | 584 | 1,070 | 73 | 1.38 | $430,291 | $88,172 |
| 2017 | 558 | 1,101 | 72 | 1.20 | $465,153 | $85,728 |
| 2016 | 711 | 1,458 | 73 | 1.58 | $522,482 | $116,749 |
| 2015 | 678 | 1,516 | 73 | 1.42 | $409,402 | $128,294 |
| 2014 | 657 | 1,450 | 73 | 1.50 | $330,515 | $116,098 |
| 2013 | 652 | 1,587 | 73 | 1.48 | $383,570 | $119,444 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 121 | $10,910 | $77 |
| New patient visit (45+ min) | 63 | $6,774 | $108 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,760 | $230 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,643 | $126 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,639 | $101 |
| Long return visit (40+ min) | 21 | $2,604 | $118 |
| Short return visit (20+ min) | 41 | $2,342 | $53 |
| New patient visit (30+ min) | 36 | $2,113 | $59 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 11 | $287 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 38 | $158 | $4 |
2022: 13 services
| New patient visit (45+ min) | 76 | $8,444 | $111 |
| Return visit (30+ min) | 86 | $7,759 | $78 |
| Biopsy of large bowel using a flexible endoscope | 31 | $4,402 | $142 |
| Short return visit (20+ min) | 64 | $3,588 | $51 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,002 | $214 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,295 | $96 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $2,129 | $89 |
| Long return visit (40+ min) | 13 | $1,620 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,406 | $64 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,290 | $99 |
| New patient visit (30+ min) | 18 | $1,141 | $63 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 11 | $319 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 52 | $195 | $4 |
2021: 11 services
| Return visit (30+ min) | 104 | $11,655 | $86 |
| New patient visit (45+ min) | 91 | $11,128 | $122 |
| Biopsy of large bowel using a flexible endoscope | 29 | $3,597 | $124 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $3,249 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,755 | $230 |
| Short return visit (20+ min) | 42 | $2,349 | $53 |
| New patient visit (30+ min) | 33 | $2,163 | $66 |
| Long return visit (40+ min) | 11 | $1,528 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $854 | $66 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 15 | $495 | $33 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 32 | $147 | $5 |
2020: 13 services
| Return visit (30+ min) | 93 | $5,858 | $60 |
| Short return visit (20+ min) | 123 | $4,566 | $34 |
| New patient visit (45+ min) | 39 | $4,485 | $115 |
| New patient visit (30+ min) | 61 | $3,480 | $57 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,857 | $136 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $1,919 | $174 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,728 | $96 |
| Long return visit (40+ min) | 16 | $1,549 | $97 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,302 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,287 | $68 |
| Biopsy of large bowel using a flexible endoscope | 11 | $1,237 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,099 | $61 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 22 | $103 | $5 |
2019: 10 services
| Short return visit (20+ min) | 312 | $17,326 | $49 |
| Return visit (30+ min) | 190 | $16,782 | $76 |
| Biopsy of large bowel using a flexible endoscope | 88 | $10,336 | $117 |
| New patient visit (30+ min) | 121 | $8,749 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 106 | $7,735 | $72 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 35 | $6,641 | $184 |
| New patient visit (45+ min) | 49 | $5,312 | $108 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,084 | $193 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,471 | $137 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,317 | $193 |
2018: 9 services
| Short return visit (20+ min) | 319 | $18,389 | $50 |
| Return visit (30+ min) | 171 | $14,568 | $74 |
| Biopsy of large bowel using a flexible endoscope | 93 | $11,302 | $122 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $7,698 | $188 |
| New patient visit (45+ min) | 58 | $7,223 | $125 |
| New patient visit (30+ min) | 94 | $6,218 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | $5,703 | $63 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,258 | $194 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $1,690 | $130 |
2017: 10 services
| Short return visit (20+ min) | 315 | $18,216 | $48 |
| Return visit (30+ min) | 162 | $14,117 | $74 |
| Biopsy of large bowel using a flexible endoscope | 109 | $12,453 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $9,620 | $200 |
| New patient visit (30+ min) | 133 | $8,703 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 91 | $6,140 | $67 |
| Diagnostic exam of large bowel using a flexible endoscope | 30 | $3,317 | $111 |
| New patient visit (45+ min) | 25 | $3,139 | $126 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,336 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,806 | $56 |
2016: 12 services
| Short return visit (20+ min) | 359 | $20,196 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $12,797 | $57 |
| Biopsy of large bowel using a flexible endoscope | 101 | $12,268 | $121 |
| Return visit (30+ min) | 143 | $12,250 | $75 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 46 | $9,326 | $203 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 111 | $8,941 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,761 | $162 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 73 | $8,468 | $109 |
| New patient visit (30+ min) | 113 | $7,107 | $63 |
| Diagnostic exam of large bowel using a flexible endoscope | 51 | $6,471 | $127 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,338 | $94 |
| New patient visit (45+ min) | 17 | $2,140 | $126 |
2015: 14 services
| Return visit (30+ min) | 227 | $22,990 | $73 |
| Short return visit (20+ min) | 319 | $18,345 | $51 |
| Biopsy of large bowel using a flexible endoscope | 94 | $15,440 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 129 | $12,782 | $56 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $9,528 | $238 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 85 | $9,261 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $9,138 | $155 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 96 | $8,140 | $81 |
| Diagnostic exam of large bowel using a flexible endoscope | 47 | $7,538 | $160 |
| New patient visit (30+ min) | 63 | $4,333 | $68 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,113 | $85 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,393 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,257 | $84 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $655 | $47 |
2014: 13 services
| Short return visit (20+ min) | 371 | $22,449 | $50 |
| Return visit (30+ min) | 178 | $20,349 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 125 | $13,030 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 95 | $10,359 | $106 |
| Biopsy of large bowel using a flexible endoscope | 64 | $10,228 | $160 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 81 | $7,282 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,555 | $160 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 30 | $4,907 | $164 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,400 | $244 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,741 | $156 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $2,805 | $112 |
| New patient visit (30+ min) | 33 | $2,643 | $80 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,241 | $95 |
2013: 15 services
| Short return visit (20+ min) | 402 | $31,947 | $52 |
| Biopsy of large bowel using a flexible endoscope | 78 | $13,126 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 120 | $12,585 | $54 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $10,483 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 83 | $9,262 | $103 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $8,492 | $230 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,359 | $145 |
| Diagnostic exam of large bowel using a flexible endoscope | 40 | $5,585 | $130 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,085 | $110 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,743 | $98 |
| New patient visit (30+ min) | 41 | $2,713 | $66 |
| Return visit (30+ min) | 30 | $2,571 | $80 |
| Short return visit | 103 | $2,011 | $19 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,196 | $80 |
| New patient visit (15+ min) | 25 | $870 | $35 |
Medicaid work
$23,666 in 2024
Medicaid paid $23,666 for 263 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 146 | $12,208 |
| Upper gastrointestinal endoscopy with biopsy | 24 | $6,053 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 26 | $2,499 |
| TISSUE EXAM BY PATHOLOGIST | 41 | $1,615 |
| Long return visit (40+ min) | 14 | $1,210 |
| Fentanyl citrate injection | 12 | $80 |
| 2024 | 263 | 6 | 31 | $23,666 |
| 2023 | 289 | 3 | 30 | $14,961 |
| 2022 | 202 | 6 | 19 | $11,026 |
| 2021 | 412 | 8 | 19 | $26,647 |
| 2020 | 47 | 1 | 19 | $3,825 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 213 | $8,331 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 64 | $6,095 |
| TISSUE EXAM BY PATHOLOGIST | 12 | $536 |
2022
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 70 | $6,249 |
| Return visit (30+ min) | 78 | $3,055 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 15 | $1,215 |
| Short return visit (20+ min) | 15 | $345 |
| Injection, diphenhydramine hcl, up to 50 mg | 12 | $91 |
| Injection, midazolam hydrochloride, per 1 mg | 12 | $71 |
2021
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 118 | $11,191 |
| COLONOSCOPY AND BIOPSY | 26 | $4,636 |
| Return visit (30+ min) | 97 | $3,945 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 43 | $3,154 |
| Upper gastrointestinal endoscopy with biopsy | 26 | $2,243 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $848 |
| Fentanyl citrate injection | 44 | $355 |
| Injection, midazolam hydrochloride, per 1 mg | 43 | $276 |
2020
| New patient visit (30+ min) | 47 | $3,825 |
Drugs they prescribed that Part D paid
$83,699
Pharmacies billed $83,699 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 583) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
471 generic and 112 brand-name prescriptions · $83,699 in drug cost · 45 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 15 | $33,490 | $2,233 |
| Linzess | 21 | $16,624 | $792 |
| Trulance | 21 | $11,500 | $548 |
| Sucralfate | 34 | $1,805 | $53 |
| Omeprazole | 159 | $1,314 | $8 |
See all 14 drugs
| Xifaxan | 15 | $33,490 | $2,233 |
| Linzess | 21 | $16,624 | $792 |
| Trulance | 21 | $11,500 | $548 |
| Sucralfate | 34 | $1,805 | $53 |
| Omeprazole | 159 | $1,314 | $8 |
| Peg 3350-Electrolyte | 50 | $1,096 | $22 |
| Colestipol | 12 | $918 | $76 |
| Famotidine | 73 | $880 | $12 |
| Lubiprostone | 14 | $584 | $42 |
| Pantoprazole | 57 | $496 | $9 |
| Neomycin Sulfate | 15 | $318 | $21 |
| Dicyclomine | 21 | $315 | $15 |
| Gavilyte-G | 15 | $300 | $20 |
| Nortriptyline | 11 | $63 | $6 |
Year by year
| 2024 | 583 | 189 | 0% (0) | 19% | $83,699 |
| 2023 | 535 | 180 | 0% (0) | None | $97,662 |
| 2022 | 516 | 205 | 0% (0) | None | $103,351 |
| 2021 | 479 | 175 | 0% (0) | None | $103,081 |
| 2020 | 774 | 280 | 0% (0) | None | $100,404 |
| 2019 | 1,314 | 366 | 0% (0) | None | $247,938 |
| 2018 | 1,023 | 288 | 0% (0) | None | $222,255 |
| 2017 | 1,017 | 323 | 0% (0) | None | $432,863 |
| 2016 | 943 | 265 | 0% (0) | None | $180,379 |
| 2015 | 1,041 | 292 | 1% (15) | None | $459,286 |
| 2014 | 993 | 267 | 1% (13) | None | $329,624 |
| 2013 | 828 | 263 | None | None | $101,672 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Xifaxan | 15 | $33,506 | $2,234 |
| Linzess | 36 | $25,594 | $711 |
| Motegrity | 14 | $13,230 | $945 |
| Movantik | 11 | $5,615 | $510 |
| Sucralfate | 35 | $3,700 | $106 |
| Omeprazole | 148 | $1,398 | $9 |
| Peg 3350-Electrolyte | 44 | $954 | $22 |
| Dicyclomine | 25 | $777 | $31 |
| Famotidine | 47 | $710 | $15 |
| Gavilyte-G | 17 | $312 | $18 |
| Pantoprazole | 36 | $267 | $7 |
| Metronidazole | 19 | $181 | $10 |
2022: 12 drugs
| Creon | 14 | $35,722 | $2,552 |
| Linzess | 31 | $20,544 | $663 |
| Movantik | 15 | $8,967 | $598 |
| Sucralfate | 48 | $8,077 | $168 |
| Lubiprostone | 17 | $5,420 | $319 |
| Peg 3350-Electrolyte | 76 | $1,579 | $21 |
| Dicyclomine | 52 | $1,023 | $20 |
| Omeprazole | 100 | $750 | $7 |
| Famotidine | 25 | $287 | $11 |
| Gavilyte-G | 13 | $217 | $17 |
| Metronidazole | 13 | $180 | $14 |
| Pantoprazole | 20 | $178 | $9 |
2021: 11 drugs
| Creon | 12 | $28,102 | $2,342 |
| Linzess | 40 | $19,512 | $488 |
| Movantik | 19 | $12,824 | $675 |
| Sucralfate | 41 | $4,415 | $108 |
| Suprep | 14 | $1,539 | $110 |
| Omeprazole | 95 | $1,305 | $14 |
| Dicyclomine | 44 | $824 | $19 |
| Peg 3350-Electrolyte | 38 | $664 | $17 |
| Pantoprazole | 26 | $420 | $16 |
| Famotidine | 22 | $304 | $14 |
| Metronidazole | 11 | $126 | $11 |
2020: 11 drugs
| Linzess | 22 | $10,109 | $459 |
| Esomeprazole Magnesium | 46 | $4,345 | $94 |
| Suprep | 30 | $3,097 | $103 |
| Dicyclomine | 99 | $2,240 | $23 |
| Pantoprazole | 149 | $2,217 | $15 |
| Omeprazole | 200 | $2,203 | $11 |
| Cholestyramine | 11 | $1,130 | $103 |
| Sucralfate | 29 | $1,073 | $37 |
| Famotidine | 38 | $498 | $13 |
| Ranitidine | 13 | $195 | $15 |
| Gavilyte-G | 14 | $172 | $12 |
2019: 18 drugs
| Apriso | 16 | $12,147 | $759 |
| Suprep | 103 | $10,228 | $99 |
| Linzess | 19 | $10,004 | $527 |
| Mesalamine | 15 | $5,970 | $398 |
| Esomeprazole Magnesium | 80 | $5,312 | $66 |
| Omeprazole | 321 | $4,146 | $13 |
| Budesonide Ec | 12 | $3,818 | $318 |
| Creon | 15 | $3,759 | $251 |
| Pantoprazole | 220 | $2,960 | $13 |
| Dicyclomine | 180 | $2,753 | $15 |
| Cholestyramine | 21 | $1,899 | $90 |
| Sucralfate | 71 | $1,776 | $25 |
| Ranitidine | 39 | $575 | $15 |
| Rabeprazole | 12 | $332 | $28 |
| Peg 3350-Electrolyte | 22 | $205 | $9 |
| Metronidazole | 20 | $188 | $9 |
| Famotidine | 25 | $169 | $7 |
| Gavilyte-C | 13 | $122 | $9 |
2018: 16 drugs
| Esomeprazole Magnesium | 56 | $10,262 | $183 |
| Apriso | 18 | $9,981 | $555 |
| Linzess | 16 | $7,005 | $438 |
| Delzicol | 16 | $7,004 | $438 |
| Mesalamine | 16 | $6,985 | $437 |
| Ursodiol | 13 | $6,794 | $523 |
| Suprep | 63 | $5,826 | $92 |
| Omeprazole | 250 | $2,623 | $10 |
| Pantoprazole | 177 | $2,352 | $13 |
| Dicyclomine | 140 | $1,371 | $10 |
| Moviprep | 11 | $1,132 | $103 |
| Sucralfate | 64 | $1,107 | $17 |
| Metronidazole | 24 | $220 | $9 |
| Ranitidine | 31 | $191 | $6 |
| Famotidine | 28 | $136 | $5 |
| Ciprofloxacin | 12 | $64 | $5 |
2017: 15 drugs
| Esomeprazole Magnesium | 60 | $10,241 | $171 |
| Delzicol | 18 | $10,007 | $556 |
| Suprep | 104 | $9,204 | $89 |
| Ursodiol | 21 | $8,645 | $412 |
| Dexilant | 19 | $5,187 | $273 |
| Linzess | 12 | $4,850 | $404 |
| Lialda | 12 | $3,209 | $267 |
| Omeprazole | 191 | $2,594 | $14 |
| Pantoprazole | 181 | $2,024 | $11 |
| Sucralfate | 77 | $1,347 | $17 |
| Rabeprazole | 12 | $1,112 | $93 |
| Dicyclomine | 115 | $970 | $8 |
| Lansoprazole | 14 | $786 | $56 |
| Metronidazole | 26 | $256 | $10 |
| Ranitidine | 21 | $189 | $9 |
2016: 13 drugs
| Esomeprazole Magnesium | 71 | $14,856 | $209 |
| Delzicol | 13 | $8,122 | $625 |
| Suprep | 94 | $7,883 | $84 |
| Linzess | 17 | $6,637 | $390 |
| Dexilant | 17 | $6,189 | $364 |
| Omeprazole | 201 | $2,857 | $14 |
| Cholestyramine | 20 | $1,666 | $83 |
| Pantoprazole | 143 | $1,553 | $11 |
| Lansoprazole | 22 | $1,317 | $60 |
| Rabeprazole | 12 | $1,103 | $92 |
| Sucralfate | 69 | $905 | $13 |
| Dicyclomine | 89 | $885 | $10 |
| Metronidazole | 12 | $103 | $9 |
2015: 20 drugs
| Nexium | 72 | $27,012 | $375 |
| Delzicol | 13 | $12,254 | $943 |
| Aciphex | 12 | $10,476 | $873 |
| Suprep | 96 | $7,770 | $81 |
| Esomeprazole Magnesium | 21 | $5,567 | $265 |
| Linzess | 17 | $5,380 | $316 |
| Apriso | 12 | $5,004 | $417 |
| Ursodiol | 19 | $4,801 | $253 |
| Omeprazole | 262 | $3,353 | $13 |
| Lansoprazole | 34 | $2,418 | $71 |
| Cholestyramine | 21 | $1,726 | $82 |
| Pantoprazole | 117 | $1,485 | $13 |
| Sucralfate | 77 | $1,445 | $19 |
| Polyethylene Glycol 3350 | 12 | $696 | $58 |
| Oxycodone | 13 | $445 | $34 |
| Dicyclomine | 58 | $437 | $8 |
| Metronidazole | 20 | $167 | $8 |
| Metoclopramide | 15 | $104 | $7 |
| Ranitidine | 11 | $90 | $8 |
| Alprazolam | 12 | $69 | $6 |
2014: 12 drugs
| Nexium | 92 | $33,771 | $367 |
| Delzicol | 13 | $10,137 | $780 |
| Aciphex | 11 | $7,559 | $687 |
| Suprep | 72 | $5,645 | $78 |
| Ursodiol | 15 | $4,264 | $284 |
| Omeprazole | 262 | $3,856 | $15 |
| Lansoprazole | 33 | $2,127 | $64 |
| Pantoprazole | 106 | $1,862 | $18 |
| Sucralfate | 90 | $1,528 | $17 |
| Dicyclomine | 60 | $383 | $6 |
| Metronidazole | 27 | $259 | $10 |
| Metoclopramide | 15 | $72 | $5 |
2013: 13 drugs
| Nexium | 79 | $27,596 | $349 |
| Aciphex | 12 | $7,717 | $643 |
| Delzicol | 11 | $6,158 | $560 |
| Omeprazole | 265 | $5,240 | $20 |
| Lansoprazole | 47 | $4,311 | $92 |
| Suprep | 54 | $3,927 | $73 |
| Carafate | 30 | $3,866 | $129 |
| Pantoprazole | 75 | $1,527 | $20 |
| Sucralfate | 49 | $1,114 | $23 |
| Dicyclomine | 50 | $316 | $6 |
| Peg 3350-Electrolyte | 19 | $211 | $11 |
| Gavilyte-C | 12 | $167 | $14 |
| Metronidazole | 15 | $150 | $10 |
Money from drug and device companies
$511 in 2025
| 2025 | 4 | 7 | None | $511 |
| 2019 | 4 | 5 | None | $381 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | None | $432 | 3 payments
|
| Abbvie | Skyrizi | $45 | 2 payments
|
| Janssen Biotech | Tremfya | $19 | 1 payment
|
| Novo Nordisk | Ozempic | $16 | 1 payment
|
See all 7 published payments
| Abbvie | Meals · 2025-12-18 | Skyrizi | $28 |
| Janssen Biotech | Meals · 2025-10-09 | Tremfya | $19 |
| Abbvie | Meals · 2025-09-03 | Rinvoq | $17 |
| Medtronic | Travel · 2025-08-08 | None | $60 |
| Medtronic | Travel · 2025-08-04 | None | $337 |
| Medtronic | Travel · 2025-08-04 | None | $35 |
| Novo Nordisk | Meals · 2025-05-21 | Ozempic | $16 |
See earlier years (2019)
2019: $381
| Intuitive Surgical | Da Vinci Surgical System | $214 | 2 payments
|
| Pfizer | Xeljanz | $125 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $22 | 1 payment
|
| Covidien LP | Chameleon | $21 | 1 payment
|
Professional record
- NPI
- 1194729152
- Licence
- CA C167727, TX J1039California C167727: Current · expires 2028-01-31Texas J1039: Active
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- TX 114957707
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X); Federal specialty code 207RI0008X (207RI0008X); Federal specialty code 207RT0003X (207RT0003X)
- Mailing address
- 950 E State Highway 114 Ste 220, Southlake, TX, 76092
- NPI first listed
- 2005-06-08
- NPI last updated
- 2025-07-28
- NPI record certified
- 2025-07-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305